Cergentis
Sabine Linn is a group leader at the Netherlands Cancer Institute and Professor of Translational Oncology at the University Medical Center Utrecht. She specializes in the molecular mechanisms underlying drug sensitivity and the development of personalised medicine.
This person is not in the org chart
This person is not in any offices
Cergentis
1 followers
Cergentis' Targeted Locus Amplification (TLA) Technology uniquely enables the targeted complete Next Generation Sequencing of any genomic locus in any genome of interest.